These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 24791879

  • 1. Baseline proteinuria, urinary osmotic pressure, and renal function as positive predictors of corticosteroids plus cyclophosphamide treatment efficacy in IgA nephropathy.
    Fang J, Li W, Li D, Tan Z.
    Chin Med J (Engl); 2014; 127(9):1710-4. PubMed ID: 24791879
    [Abstract] [Full Text] [Related]

  • 2. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 3. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
    Sarcina C, Tinelli C, Ferrario F, Pani A, De Silvestri A, Scaini P, Del Vecchio L, Alberghini E, Buzzi L, Baragetti I, Pozzi C.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):973-981. PubMed ID: 27129712
    [Abstract] [Full Text] [Related]

  • 4. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
    Hwang HS, Kim BS, Shin YS, Yoon HE, Song JC, Choi BS, Park CW, Yang CW, Kim YS, Bang BK.
    Nephrology (Carlton); 2010 Mar 06; 15(2):236-41. PubMed ID: 20470285
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the effectiveness of cyclophosphamide, leflunomide, corticosteroids, or conservative management alone in patients with IgA nephropathy: a retrospective observational study.
    Chen S, Yin Q, Ren S, Zhong X, Wang W, Li G, Wang L.
    Sci Rep; 2018 Sep 12; 8(1):13662. PubMed ID: 30209279
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolic acid therapy after cyclophosphamide pulses in progressive IgA nephropathy.
    Rasche FM, Keller F, von Müller L, Sailer LK, Karges W, Czock D.
    J Nephrol; 2006 Sep 12; 19(4):465-72. PubMed ID: 17048204
    [Abstract] [Full Text] [Related]

  • 7. Treatment of IgA nephropathy.
    Pozzi C.
    J Nephrol; 2016 Feb 12; 29(1):21-5. PubMed ID: 26577268
    [Abstract] [Full Text] [Related]

  • 8. Corticosteroid therapy in IgA nephropathy with minimal proteinuria and high renal pathological score: A single‑center cohort study.
    Tang Y, He H, Sun W, Hu P, Chen X, Xu X.
    Mol Med Rep; 2018 Oct 12; 18(4):4103-4112. PubMed ID: 30132546
    [Abstract] [Full Text] [Related]

  • 9. Corticosteroids or immunosuppressants were not superior to supportive care in IgA nephropathy patients with mild proteinuria.
    Pei G, Tan J, Tang Y, Tan L, Zhong Z, Zhou L, Chen C, Qin W.
    Medicine (Baltimore); 2020 Jun 12; 99(24):e20513. PubMed ID: 32541473
    [Abstract] [Full Text] [Related]

  • 10. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.
    Clin Exp Nephrol; 2004 Sep 12; 8(3):237-42. PubMed ID: 15480901
    [Abstract] [Full Text] [Related]

  • 11. Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol.
    Eitner F, Ackermann D, Hilgers RD, Floege J.
    J Nephrol; 2008 Sep 12; 21(3):284-9. PubMed ID: 18587715
    [Abstract] [Full Text] [Related]

  • 12. Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.
    Rauen T, Fitzner C, Eitner F, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JFE, Hilgers RD, Floege J.
    J Am Soc Nephrol; 2018 Jan 12; 29(1):317-325. PubMed ID: 29042456
    [Abstract] [Full Text] [Related]

  • 13. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
    Uzu T, Harada T, Ko M, Yamato M, Takahara K, Yamauchi A.
    Clin Exp Nephrol; 2003 Sep 12; 7(3):210-4. PubMed ID: 14586717
    [Abstract] [Full Text] [Related]

  • 14. Predictors of poor outcomes in steroid therapy for immunoglobulin A nephropathy.
    Shimizu A, Takei T, Uchida K, Tsuchiya K, Nitta K.
    Nephrology (Carlton); 2009 Aug 12; 14(5):521-6. PubMed ID: 19674320
    [Abstract] [Full Text] [Related]

  • 15. Reduction of proteinuria by therapeutic intervention improves the renal outcome of elderly patients with IgA nephropathy.
    Okabayashi Y, Tsuboi N, Haruhara K, Kanzaki G, Koike K, Shimizu A, Miyazaki Y, Ohno I, Kawamura T, Ogura M, Yokoo T.
    Clin Exp Nephrol; 2016 Dec 12; 20(6):910-917. PubMed ID: 26830548
    [Abstract] [Full Text] [Related]

  • 16. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW, Fluck RJ, Lambie SH.
    Clin Nephrol; 2001 Sep 12; 56(3):193-8. PubMed ID: 11597033
    [Abstract] [Full Text] [Related]

  • 17. Corticosteroids could improve the renal outcome of IgA nephropathy with moderate proteinuria.
    Zhong Z, Tang Y, Tan J, Tan L, Pei G, Qin W.
    Int Urol Nephrol; 2021 Jan 12; 53(1):121-127. PubMed ID: 32944888
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of corticosteroid therapy for IgA nephropathy patients stratified by kidney function and proteinuria.
    Nagasawa Y, Yamamoto R, Shinzawa M, Shoji T, Hasuike Y, Nagatoya K, Yamauchi A, Hayashi T, Kuragano T, Moriyama T, Isaka Y.
    Clin Exp Nephrol; 2020 Oct 12; 24(10):927-934. PubMed ID: 32642919
    [Abstract] [Full Text] [Related]

  • 19. Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.
    Tesar V, Troyanov S, Bellur S, Verhave JC, Cook HT, Feehally J, Roberts IS, Cattran D, Coppo R, VALIGA study of the ERA-EDTA Immunonephrology Working Group.
    J Am Soc Nephrol; 2015 Sep 12; 26(9):2248-58. PubMed ID: 25677392
    [Abstract] [Full Text] [Related]

  • 20. Statins stabilize the renal function of IgA nephropathy.
    Moriyama T, Oshima Y, Tanaka K, Iwasaki C, Ochi A, Itabashi M, Takei T, Uchida K, Nitta K.
    Ren Fail; 2014 Apr 12; 36(3):356-60. PubMed ID: 24341619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.